Role of proximal tubule in the hypocalciuric response to thiazide of patients with idiopathic hypercalciuria

American Journal of Physiology - Renal Physiology

Volumn 305, Issue 4, 2013, Pages

  Bergsland, Kristin J ^a   Worcester, Elaine M ^a   Coe, Fredric L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Calcium oxalate; Calcium phosphate; Idiopathic hypercalciuria; Kidney calculi; Thiazide

Indexed keywords

CALCIUM OXALATE; CALCIUM PHOSPHATE; CHLORTALIDONE; LITHIUM ION; MAGNESIUM; PHOSPHORUS;

ARTICLE; CALCIUM EXCRETION; CALCIUM OXALATE STONE; CLINICAL ARTICLE; CONTROLLED STUDY; FOOD INTAKE; HUMAN; IDIOPATHIC HYPERCALCIURIA; KIDNEY PROXIMAL TUBULE; MALE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RECURRENT DISEASE; SODIUM ABSORPTION; SODIUM BLOOD LEVEL; STONE FORMATION;

EID: 84881653526     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00116.2013     Document Type: Article

References (42)

1. Asplin JR, Parks JH, Coe FL. Dependence of upper limit of metastability on supersaturation in nephrolithiasis. Kidney Int 52: 1602-1608, 1997.
2. Bergsland KJ, Coe FL, Gillen DL, Worcester EM. A test of the hypothesis that the collecting duct calcium-sensing receptor limits rise of urine calcium molarity in hypercalciuric calcium kidney stone formers. Am J Physiol Renal Physiol 297: F1017-F1023, 2009.
3. Bergsland KJ, Zisman AL, Asplin JR, Worcester EM, Coe FL. Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones. Am J Physiol Renal Physiol 300: F311-F318, 2011.
4. Borghi L, Meschi T, Guerra A, Novarini A. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol 22 Suppl 6: S78-S86, 1993.
5. Bowers GN Jr., and Rains TC. Measurement of total calcium in biological fluids: flame atomic absorption spectrometry. Methods Enzymol 158: 302-319, 1988.
6. Breslau N, Moses AM, Weiner IM. The role of volume contraction in the hypocalciuric action of chlorothiazide. Kidney Int 10: 164-170, 1976.
7. Brickman AS, Massry SG, Coburn JW. Changes in serum and urinary calcium during treatment with hydrochlorothiazide: studies on mechanisms. J Clin Invest 51: 945-954, 1972.
8. Ceylan K, Topal C, Erkoc R, Sayarlioglu H, Can S, Yilmaz Y, Dogan E, Algun E, Gonulalan H. Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease. Ann Pharmacother 39: 1034-1038, 2005.
9. Coe FL, Canterbury JM, Firpo JJ, Reiss E. Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J Clin Invest 52: 134-142, 1973.
10. Coe FL, Evan AP, Lingeman JE, Worcester EM. Plaque and deposits in nine human stone diseases. Urol Res 38: 239-247, 2010.
11. Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med 327: 1141-1152, 1992.
12. Coe FL, Parks JH, Bushinsky DA, Langman CB, Favus MJ. Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria. Kidney Int 33: 1140-1146, 1988.
13. Ettinger B, Citron JT, Livermore B, Dolman LI. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 139: 679-684, 1988.
14. Evan A, Lingeman J, Coe FL, Worcester E. Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int 69: 1313-1318, 2006.
15. Evan AP, Coe FL, Lingeman JE, Shao Y, Sommer AJ, Bledsoe SB, Anderson JC, Worcester EM. Mechanism of formation of human calcium oxalate renal stones on Randall's plaque. Anat Rec (Hoboken) 290: 1315-1323, 2007.
16. Hoenderop JG, Nilius B, Bindels RJ. Calcium absorption across epithelia. Physiol Rev 85: 373-422, 2005.
17. Jang HR, Kim S, Heo NJ, Lee JH, Kim HS, Nielsen S, Jeon US, Oh YK, Na KY, Joo KW, Han JS. Effects of thiazide on the expression of TRPV5, calbindin-D28K, and sodium transporters in hypercalciuric rats. J Korean Med Sci 24 Suppl: S161-S169, 2009.
18. Kirchner KA. Lithium as a marker for proximal tubular delivery during low salt intake and diuretic infusion. Am J Physiol Renal Fluid Electrolyte Physiol 253: F188-F196, 1987.
19. Kuo RL, Lingeman JE, Evan AP, Paterson RF, Parks JH, Bledsoe SB, Munch LC, Coe FL. Urine calcium and volume predict coverage of renal papilla by Randall's plaque. Kidney Int 64: 2150-2154, 2003.
20. Laerum E, Larsen S. Thiazide prophylaxis of urolithiasis. A double-blind study in general practice. Acta Med Scand 215: 383-389, 1984.
21. Lamberg BA, Kuhlback B. Effect of chlorothiazide and hydrochlorothiazide on the excretion of calcium in urine. Scand J Clin Lab Invest 11: 351-357, 1959.
22. Lauderdale DS, Thisted RA, Wen M, Favus MJ. Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey. J Bone Miner Res 16: 1893-1898, 2001.
23. Lee CT, Shang S, Lai LW, Yong KC, Lien YH. Effect of thiazide on renal gene expression of apical calcium channels and calbindins. Am J Physiol Renal Physiol 287: F1164-F1170, 2004.
24. Lemann J Jr, Gray RW, Maierhofer WJ, Cheung HS. Hydrochlorothiazide inhibits bone resorption in men despite experimentally elevated serum 1,25-dihydroxyvitamin D concentrations. Kidney Int 28: 951-958, 1985.
25. Na KY, Oh YK, Han JS, Joo KW, Lee JS, Earm JH, Knepper MA, Kim GH. Upregulation of Na_ transporter abundances in response to chronic thiazide or loop diuretic treatment in rats. Am J Physiol Renal Physiol 284: F133-F143, 2003.
26. Nicar MJ, Peterson R, Pak CY. Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis. J Urol 131: 430-433, 1984.
27. 2+ transport proteins in kidney. Kidney Int 64: 555-564, 2003.
28. 2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest 115: 1651-1658, 2005.
29. Oh MS. External balance of electrolytes and acids and alkali. In: Seldin and Giebisch's The Kidney: Physiology & Pathophysiology, edited by Alpern RJ, Caplan MJ, and Moe OW. London: Elsevier, 2013, p. 291-318.
30. Parfitt AM. The interactions of thiazide diuretics with parathyroid hormone and vitamin D. Studies in patients with hypoparathyroidism. J Clin Invest 51: 1879-1888, 1972.
31. Rouse D, Ng RC, Suki WN. Calcium transport in the pars recta and thin descending limb of Henle of the rabbit, perfused in vitro. J Clin Invest 65: 37-42, 1980.
32. Suki WN, Hull AR, Rector FC Jr., Seldin DW. Mechanisms of the effect of thiazide diuretics on calcium and uric acid. J Clin Invest 46: 1121, 1967.
33. Sutton RA. Diuretics and calcium metabolism. Am J Kidney Dis 5: 4-9, 1985.
34. Tarazi RC, Dustan HP, Frohlich ED. Long-term thiazide therapy in essential hypertension. Evidence for persistent alteration in plasma volume and renin activity. Circulation 41: 709-717, 1970.
35. Thomsen K, Shirley DG. A hypothesis linking sodium and lithium reabsorption in the distal nephron. Nephrol Dial Transplant 21: 869-880, 2006.
36. Tiselius HG. Solution chemistry of supersaturation. In: Kidney Stones: Medical and Surgical Management, edited by Coe FL, Favus MJ, and Pak CYC. Philadelphia, PA: Lippincott-Raven, 1996, p. 33-64.
37. Van Den Berg CJ, Tucker RM, Dousa TP. Idiopathic hypercalciuria: hydrochlorothiazide decrease urinary calcium without altered renal response to parathyroid hormone. J Clin Endocrinol Metab 55: 23-26, 1982.
38. Werness PG, Brown CM, Smith LH, Finlayson B. EQUIL2: a BASIC computer program for the calculation of urinary saturation. J Urol 134: 1242-1244, 1985.
39. Woelfel A, Kaplan RA, Pak CY. Effect of hydrochlorothiazide therapy on the crystallization of calcium oxalate in urine. Metabolism 26: 201-205, 1977.
40. Worcester EM, Coe FL. New insights into the pathogenesis of idiopathic hypercalciuria. Semin Nephrol 28: 120-132, 2008.
41. Worcester EM, Coe FL, Evan AP, Bergsland KJ, Parks JH, Willis LR, Clark DL, Gillen DL. Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patients. Am J Physiol Renal Physiol 295: F1286-F1294, 2008.
42. Worcester EM, Gillen DL, Evan AP, Parks JH, Wright K, Trumbore L, Nakagawa Y, Coe FL. Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am J Physiol Renal Physiol 292: F66-F75, 2007.